Literature DB >> 32813258

Effects of photobiomodulation on cellular viability and cancer stem cell phenotype in oral squamous cell carcinoma.

Ana Melissa Ccopa Ibarra1, Mônica Pereira Garcia1, Marlene Ferreira1, Daniela de Fátima Teixeira da Silva1, Christiane Pavani1, Raquel Agnelli Mesquita-Ferrari1, Kristianne Porta Santos Fernandes1, Fabio Daumas Nunes2, Maria Fernanda Setúbal Destro Rodrigues3,4.   

Abstract

Oral squamous cell carcinoma (OSCC) is the most common head and neck malignancy; it has been shown that cancer stem cells (CSC) are present in OSCC and associated with tumor growth, invasion, metastasis, and therapeutic resistance. Photobiomodulation (PBM) is an alternative tool for oncologic treatment adverse effects such as oral mucositis (OM); however, controversy exists regarding the undesirable effects of PBM on tumor or CSC. This study aimed to evaluate in vitro, the effects of PBM, with the same dosimetric parameters as those used in the clinic for OM prevention and treatment, on OSCC cellular viability, as well as PBM's effect on CSC properties and its phenotype. OSCC cell lines were submitted to single or daily PBM with 3 J/cm2 and 6 J/cm2 and then the cellular viability was evaluated by MTT, NRU (neutral red uptake), and CVS (crystal violet staining). The CSC populations were evaluated by clonogenic formation assay, flow cytometry, and RT-qPCR. The single PBM with the 3 J/cm2 group was associated with increased cellular viability. Daily PBM with 3 J/cm2 and 6 J/cm2 was associated with a significant decrease in cellular viability. Additionally, daily PBM was not able to promote CSC self-renewal or the CD44high/ESAlow and CD44high/ESAhigh cellular phenotypes. Moreover, a decrease in the number of spheres and in the expression of the CSC related gene BMI1 was observed after daily PBM with 6 J/cm2. Daily PBM with 3 J/cm2 and 6 J/cm2 showed an inhibitory effect on cellular viability and was not able to promote the CSC self-renewal or phenotype.

Entities:  

Keywords:  Cancer stem cells; Low-level laser therapy; Oral squamous cell carcinoma; Photobiomodulation

Year:  2020        PMID: 32813258     DOI: 10.1007/s10103-020-03131-x

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  26 in total

1.  Correlation of ALDH1, CD44, OCT4 and SOX2 in tongue squamous cell carcinoma and their association with disease progression and prognosis.

Authors:  Cong-Fa Huang; Xiao-Rong Xu; Tian-Fu Wu; Zhi-Jun Sun; Wen-Feng Zhang
Journal:  J Oral Pathol Med       Date:  2014-01-23       Impact factor: 4.253

2.  Photomodulation of the osteoclastogenic potential of oral squamous carcinoma cells.

Authors:  Tatiana Dias Schalch; Kristianne Porta Santos Fernandes; João Costa-Rodrigues; Mônica Pereira Garcia; Raquel Agnelli Mesquita-Ferrari; Sandra Kalil Bussadori; Maria Helena Fernandes
Journal:  J Biophotonics       Date:  2016-04-18       Impact factor: 3.207

3.  Survival after free flap reconstruction in patients with advanced oral squamous cell carcinoma.

Authors:  Juan Carlos de Vicente; Tania Rodríguez-Santamarta; Pablo Rosado; Ignacio Peña; Lucas de Villalaín
Journal:  J Oral Maxillofac Surg       Date:  2012-02       Impact factor: 1.895

Review 4.  Could the biological robustness of low level laser therapy (Photobiomodulation) impact its use in the management of mucositis in head and neck cancer patients.

Authors:  Stephen T Sonis; Sepehr Hashemi; Joel B Epstein; Raj G Nair; Judith E Raber-Durlacher
Journal:  Oral Oncol       Date:  2016-02-03       Impact factor: 5.337

5.  Distant metastases in head and neck cancer.

Authors:  Fréderic Duprez; Dieter Berwouts; Wilfried De Neve; Katrien Bonte; Tom Boterberg; Philippe Deron; Wouter Huvenne; Sylvie Rottey; Marc Mareel
Journal:  Head Neck       Date:  2017-06-26       Impact factor: 3.147

6.  Long-term survival of a randomized phase III trial of head and neck cancer patients receiving concurrent chemoradiation therapy with or without low-level laser therapy (LLLT) to prevent oral mucositis.

Authors:  Héliton S Antunes; Daniel Herchenhorn; Isabele A Small; Carlos M M Araújo; Celia Maria Pais Viégas; Gabriela de Assis Ramos; Fernando L Dias; Carlos G Ferreira
Journal:  Oral Oncol       Date:  2017-06-03       Impact factor: 5.337

7.  Low-level laser therapy promotes proliferation and invasion of oral squamous cell carcinoma cells.

Authors:  Águida Cristina Gomes Henriques; Fernanda Ginani; Ruth Medeiros Oliveira; Tatjana Souza Lima Keesen; Carlos Augusto Galvão Barboza; Hugo Alexandre Oliveira Rocha; Jurema Freire Lisboa de Castro; Ricardo Della Coletta; Roseana de Almeida Freitas
Journal:  Lasers Med Sci       Date:  2014-02-14       Impact factor: 3.161

8.  Low-level laser therapy can produce increased aggressiveness of dysplastic and oral cancer cell lines by modulation of Akt/mTOR signaling pathway.

Authors:  Felipe F Sperandio; Fernanda S Giudice; Luciana Corrêa; Décio S Pinto; Michael R Hamblin; Suzana C O M de Sousa
Journal:  J Biophotonics       Date:  2013-04-02       Impact factor: 3.207

9.  Prognostic implications of CD44, NANOG, OCT4, and BMI1 expression in tongue squamous cell carcinoma.

Authors:  Maria Fernanda Setúbal Destro Rodrigues; Flávia Caló de Aquino Xavier; Nathália Paiva Andrade; Camila Lopes; Lucyene Miguita Luiz; Bruno Tavares Sedassari; Ana Melissa Ccopa Ibarra; Rossana Verónica Mendoza López; Claudia Kliemann Schmerling; Raquel Ajub Moyses; Eloiza Elena Tajara da Silva; Fabio Daumas Nunes
Journal:  Head Neck       Date:  2018-04-01       Impact factor: 3.147

10.  Cisplatin induces Bmi-1 and enhances the stem cell fraction in head and neck cancer.

Authors:  Carolina Nör; Zhaocheng Zhang; Kristy A Warner; Lisiane Bernardi; Fernanda Visioli; Joseph I Helman; Rafael Roesler; Jacques E Nör
Journal:  Neoplasia       Date:  2014-02       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.